Travere Therapeutics (TVTX) Goodwill & Intangibles (2013 - 2026)

Travere Therapeutics' Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $110.0 million for Q1 2026.

• Quarterly Goodwill & Intangibles rose 5.18% year-over-year to $110.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $110.0 million (up 5.18% YoY) and the FY2025 annual result came in at $113.9 million, up 8.68% from the prior year.
• Goodwill & Intangibles was $110.0 million for Q1 2026 at Travere Therapeutics, down from $113.9 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $163.8 million in Q1 2023 and bottomed at $97.9 million in Q4 2022.
• A 5-year average of $120.5 million and a median of $107.7 million in 2023 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2024 — Goodwill & Intangibles sank 37.73% — and 2025, when it increased 8.68%.
• Travere Therapeutics' Goodwill & Intangibles stood at $97.9 million in 2022, then grew by 7.53% to $105.2 million in 2023, then slipped by 0.45% to $104.8 million in 2024, then advanced by 8.68% to $113.9 million in 2025, then retreated by 3.36% to $110.0 million in 2026.
• Business Quant data shows TVTX's Goodwill & Intangibles at $110.0 million in Q1 2026, $113.9 million in Q4 2025, and $110.2 million in Q3 2025.